Jnba Financial Advisors Ionis Pharmaceuticals Inc Transaction History

Jnba Financial Advisors

8 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2023 Nov 02, 2023	BUY	$38.5 - $47.13 $269 - $329	7 New	7 $0
Q1 2021 May 03, 2021	SELL	$42.51 - $63.78 $85 - $127	-2 Closed	0 $0
Q4 2020 Jan 25, 2021	BUY	$45.3 - $60.27 $90 - $120	2 New	2 $0
Q3 2019 Nov 01, 2019	SELL	$59.06 - $72.15 $7,736 - $9,451	-131 Closed	0 $0
Q2 2019 Jul 26, 2019	BUY	$62.09 - $86.14 $6,209 - $8,614	100 Added 322.58%	131 $8,000
Q4 2018 Feb 07, 2019	BUY	$43.37 - $59.54 $1,344 - $1,845	31 New	31 $2,000
Q3 2018 Nov 01, 2018	SELL	$42.88 - $53.7 $1,329 - $1,664	-31 Closed	0 $0
Q2 2017 Aug 14, 2017	BUY	N/A	31	31 $2,000

412

140M

829K

789K

Ticker IONS
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 141,940,992
Market Cap $4.8B
Description
Ionis Pharmaceuticals, Inc. discovers and develops RNA-targeted therapeutics in the United States. The company offers SPINRAZA for spinal muscular atrophy (SMA) in pediatric and adult patients; TEGSEDI, an injection for the treatment of polyneuropathy of hereditary transthyretin-mediated amyloidosis in adults; and WAYLIVRA, a treatment for famil...

Get notified when there are updates to the investment portfolio of Jnba Financial Advisors, based on Form 13F filings with the SEC.

Stay updated on Jnba Financial Advisors with notifications on news.